09:22 AM EST - Oncolytics Biotech Inc. : Today announced the presentation of additional translational data from the AWARE-1 breast cancer window-of-opportunity study conducted in combination with SOLTI-Innovative Cancer Research at The San Antonio Breast Cancer Symposium (SABCS). Oncolytics Biotech Inc.
shares T.ONC are trading unchanged at $1.88.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=7392558813975023
